GPT and metabolic dysfunction-associated steatohepatitis: Abdel-Razik et al. reported that after rifaximin therapy (1100 mg/day for 6 months), patients with NASH showed an evidently reduced levels of proinflammatory cytokines, ALT and NAFLD-liver fat score [48].